Edition:
United Kingdom

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

22.82USD
20 Nov 2017
Change (% chg)

$-0.08 (-0.35%)
Prev Close
$22.90
Open
$22.90
Day's High
$23.10
Day's Low
$22.70
Volume
77,047
Avg. Vol
98,899
52-wk High
$33.21
52-wk Low
$21.53

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
FY 2016 Dec '16 0.00 -0.491
Sep '16 0.00 -0.499
Jun '16 0.00 -0.623
Mar '16 0.00 -0.646
FY 2015 Dec '15 0.00 -0.244
Sep '15 0.00 -0.577
Jun '15 0.00 -1.517
Mar '15 0.00 -1.612
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.65 1.00 0.00 --
Quarter Ending Mar-18 1 1.00 1.00 1.00 --
Year Ending Dec-17 5 1.22 1.70 0.70 0.00
Year Ending Dec-18 5 28.53 43.00 18.58 73.30
Earnings (per share)
Quarter Ending Dec-17 5 -0.91 -0.84 -1.04 --
Quarter Ending Mar-18 1 -1.73 -1.73 -1.73 --
Year Ending Dec-17 4 -2.59 -2.51 -2.65 -3.07
Year Ending Dec-18 5 -3.83 -2.11 -4.83 -1.70
LT Growth Rate (%) 1 66.00 66.00 66.00 72.40
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 89.24 32.96
P/E High - Last 5 Yrs. -- 293.80 45.57
P/E Low - Last 5 Yrs. -- 94.62 24.35
Beta -- 0.85 0.89
Price to Sales (TTM) -- 86.58 5.25
Price to Book (MRQ) 4.39 13.59 5.40
Price to Tangible Book (MRQ) 4.93 13.47 6.73
Price to Cash Flow (TTM) -- 76.92 23.58
% Owned Institutions 86.59 6.31 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.27 1.49
Dividend 5 Year Growth Rate -- 1.88 5.23
Payout Ratio(TTM) -- 17.27 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 437.56 8.84
Sales (TTM) vs TTM 1 Yr. Ago -- 70.22 5.41
Sales - 5 Yr. Growth Rate -- 33.80 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 10.43 29.93 19.37
EPS (TTM) vs TTM 1 Yr. Ago 2.93 -- --
EPS - 5 Yr. Growth Rate -- 43.61 10.96
Capital Spending - 5 Yr. Growth Rate -- 41.13 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.69 2.20
Current Ratio (MRQ) 21.00 5.29 3.00
LT Debt to Equity (MRQ) 0.00 18.84 10.82
Total Debt to Equity (MRQ) 0.00 20.43 14.95
Interest Coverage (TTM) -- -113.11 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.40 54.68
Gross Margin - 5 Yr. Avg. -- 51.61 52.15
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -233.75 15.51
Operating Margin (TTM) -- -434.93 9.27
Operating Margin - 5 Yr. Avg. -- -249.73 11.18
Pre-Tax Margin (TTM) -- -410.79 10.08
Pre-Tax Margin - 5 Yr. Avg. -- -249.04 11.61
Net Profit Margin (TTM) -- -412.35 6.37
Net Profit Margin - 5 Yr. Avg. -- -251.98 7.88
Effective Tax Rate (TTM) -- 23.97 23.20
Effective Tax Rate - 5 Yr. Avg. -- 19.28 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,591,874 876,721,579
Net Income/Employee (TTM) -1,598,903 3,388,969 103,151,091
Receivable Turnover (TTM) -- 21.69 5.78
Inventory Turnover (TTM) -- 2.02 3.35
Asset Turnover (TTM) 0.00 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -36.33 -0.31 11.10
Return on Assets - 5 Yr. Avg. -- 0.00 12.57
Return on Investment (TTM) -38.27 2.53 14.58
Return on Investment - 5 Yr. Avg. -- 3.09 16.46
Return on Equity (TTM) -38.37 3.17 16.09
Return on Equity - 5 Yr. Avg. -- 6.58 17.62
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -95.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.58 -2.89 50 53
13 Week -1.71 -6.50 51 61
26 Week -14.92 -21.38 38 69
52 Week 12.14 -4.95 60 47
YTD 1.73 -10.66 48 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 92.25%
# of Holders: 156
Total Shares Held: 27,671,240
3 Mo. Net Change: 1,788,122
# New Positions: 15
# Closed Positions: 13
# Increased Positions: 83
# Reduced Positions: 43
# Net Buyers: 40
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.